メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
高橋 雅英
研究統括監理室
h-index
18049
被引用数
70
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1981 …
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(341)
類似のプロファイル
(6)
フィンガープリント
Masahide Takahashiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
100%
Mouse
99%
Tyrosine
76%
Tyrosine Kinase
74%
Glial Cell Line-Derived Neurotrophic Factor
72%
Fibroblast
70%
Phosphotransferase
66%
Kinase
66%
Proto Oncogene
64%
Cancer Cell
55%
Actin
50%
Cell Migration
46%
Signal Transduction
44%
Cysteine
43%
Surface Property
37%
Dimerization
32%
RET Proto-Oncogene
30%
Enhancer Region
29%
C-Terminus
26%
Eicosanoid Receptor
26%
Enzyme
26%
Actin-Binding Protein
25%
Germline Mutation
24%
Transgenic Mouse
24%
Cytoskeleton
24%
Oncogene
23%
Serine
22%
Phosphoinositide 3-Kinase
22%
Amino Acids
22%
N-Terminus
21%
Epidermal Growth Factor Receptor
21%
Isoform
21%
Codon
21%
Stem Cell
20%
Transfection
20%
Disulfide
20%
Cadherin
20%
Promoter Region
19%
Cell Motility
19%
Tumor Progression
18%
Exon
18%
Angiogenesis
18%
Oncogene Ret
16%
Intravenous Immunoglobulin
16%
Filopodia
16%
Point Mutation
15%
Carcinogenesis
15%
Stem Cell Marker
15%
Wnt Signaling Pathway
15%
Glycoprotein
15%
Medicine and Dentistry
Neoplasm
41%
Proto Oncogene
40%
Cadmium 109
39%
Malignant Neoplasm
35%
Cancer Cell
33%
Transgenic Mouse
30%
Protein Tyrosine Kinase
26%
Cancer Associated Fibroblast
26%
Multiple Endocrine Neoplasia
26%
Glial Cell Line Derived Neurotrophic Factor
24%
Disease
24%
Oncogene
22%
Lung Cancer
20%
Cell Migration
19%
Papillary Thyroid Cancer
19%
Stroma
18%
Multiple Endocrine Neoplasia Type 2b
18%
Protein Ret
18%
Thyroid Cancer
16%
Breast Cancer
16%
Nodular Melanoma
16%
Signal Transduction
16%
Hirschsprung's Disease
16%
Biological Marker
15%
Actin Binding Protein
15%
Tumor Progression
15%
Actin
15%
Melanocytic Tumor
15%
Thyroid Medullary Carcinoma
15%
Tumor Cell
13%
Cytoskeleton
12%
Multiple Endocrine Neoplasia Type 2
12%
Pancreas Cancer
12%
Tumor Invasion
12%
Oncogene Ret
11%
Fibroblast
11%
Phosphotransferase
11%
Kidney Hypoplasia
11%
Ganglioglioma
11%
Immunotherapy
11%
Stem Cell
11%
Neurotropic Agent
11%
Fibrosis
11%
Finger
11%
Intestine Innervation
10%
Point Mutation
10%
Exon
10%
Metastatic Carcinoma
10%
Receptor
9%
In Vitro
9%
Keyphrases
Multiple Endocrine Neoplasia Type 2 (MEN2)
43%
RET Proto-oncogene
42%
Glial Cell Line-derived Neurotrophic Factor
32%
Oncogene
29%
CD109
28%
RET Tyrosine Kinase
25%
Girdin
22%
Hirschsprung Disease
22%
Transforming Activity
22%
Tyrosine
21%
Tyrosine Kinase
19%
Kinase Activity
18%
Kinase Domain
18%
Tyrosine Phosphorylation
18%
Tyrosine Residue
17%
Oncogene Products
17%
Pancreatic Cancer
16%
RET Signaling
16%
MEN2B
15%
Phosphoinositide 3-kinase (PI3K)
15%
Signaling Pathway
14%
Neurotrophic Factors
14%
Mouse Mammary Tumor Virus
14%
Neuroblastoma Cells
13%
Complementary DNA (cDNA)
12%
Sandwich Immunoassay
12%
Amino Acids
12%
Associated Proteins
11%
Cancer-associated Fibroblasts
11%
RET Kinase
11%
Superactivation
11%
Thyroid Cancer
11%
Prognostic Diagnosis
11%
Pharmacologic Conversion
11%
Pro-tumor
11%
Endothelial Progenitor Cells
11%
C-Ret
11%
Dimerization
10%
Tumor Cells
10%
Transgenic Mice
10%
Expression Level
10%
Tumor
10%
Germline mutation
10%
SK-N-MC Cells
10%
Extracellular Domain
9%
Amino
9%
Phenylalanine
9%
Medullary Thyroid Carcinoma
8%
Phosphotyrosine Binding Domains
8%
Cysteine
8%
